Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain.
Yu X, Liu H, Hamel KA, Morvan MG, Yu S, Leff J, Guan Z, Braz JM, Basbaum AI. · 2020
Read Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain. by Yu X, Liu H, Hamel KA, Morvan MG, Yu S, Leff J, Guan Z, Braz JM, Basbaum AI. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6959328.txt.
Introduction
Yu and co-authors show that immune cells near sensory neurons help start and sustain nerve pain. Their study appeared in Nature Communications. After peripheral nerve injury, macrophages multiply around sensory neuron cell bodies in the dorsal root ganglia. Whether that expansion truly drives pain was unclear.
Removing those ganglion macrophages eased the mechanical hypersensitivity of neuropathic pain, in both male and female mice. Macrophages at the injury site itself did not have that role. Signals from injured sensory neurons coaxed the macrophages to grow. A growth factor from the neurons, CSF1, mattered mainly in males, where it also switched on spinal microglia. Even so, fewer macrophages built up in females. The findings point to drug targets on the body's periphery, rather than in the spinal cord.
Catalog record
| CREATOR | Yu X, Liu H, Hamel KA, Morvan MG, Yu S, Leff J, Guan Z, Braz JM, Basbaum AI. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain By Xiaobing Yu, Hongju Liu, Katherine A. Hamel, Maelig G. Morvan, Stephen Yu, Jacqueline Leff, Zhonghui Guan, Joao M. Braz, Allan I. Basbaum Published in: Nature Communications DOI: 10.1038/s41467-019-13839-2 ABSTRACT Paralleling the activation of dorsal horn microglia after peripheral nerve injury is a significant expansion and proliferation of macrophages around injured sensory neurons in dorsal root ganglia (DRG). Here we demonstrate a critical contribution of DRG macrophages, but not those at the nerve injury site, to both the initiation and maintenance of the mechanical hypersensitivity that characterizes the neuropathic pain phenotype. In contrast to the reported sexual dimorphism in the microglial contribution to neuropathic pain, depletion of DRG macrophages reduces nerve injury-induced mechanical hypersensitivity and expansion of DRG macrophages in both male and female mice. However, fewer macrophages are induced in the female mice and deletion of colony-stimulating factor 1 from sensory neurons, which prevents nerve injury-induced microglial activation and proliferation, only reduces macrophage expansion in male mice. Finally, we demonstrate molecular cross-talk between axotomized sensory neurons and macrophages, revealing potential peripheral DRG targets for neuropathic pain management. INTRODUCTION There is now considerable evidence that molecular and cellular interactions among spinal dorsal horn neurons and microglia, the resident macrophages of the central nervous system (CNS), are important contributors to the induction and maintenance of neuropathic pain following peripheral nerve injury1,2. Paralleling the activation of dorsal horn microglia after peripheral nerve injury, several recent studies demonstrated that there is also a significant increase in the number of macrophages in dorsal root ganglia (DRG) ipsilateral to the injury3,4, suggesting that pro-nociceptive neuronal and non-neuronal cellular interactions also occur in the DRG. Unclear, however, is the extent to which the increase of DRG macrophages contributes to the pain phenotype induced by nerve injury. To address this question, pharmacological and genetic approaches have been used to examine the behavioral consequence of depleting DRG macrophages in a nerve injury setting. For example, Cobos et al.5 reported that clodronate-mediated killing of DRG macrophages reduced the mechanical allodynia induced by nerve injury. However, other groups could not confirm those findings6–9, conceivably due to variability in the efficacy of clodronate5,6. Other studies demonstrated clodronate killing of macrophages in injured peripheral nerves and concluded that these macrophages were critical to the neuropathic pain development10,11. However, as these studies did not examine the DRG, the contribution of DRG macrophages could not be ruled out. Selective CSF1 receptor (CSF1R) antagonists have also been used to induce cell death, by blocking CSF1 signaling to macrophages. However, as these CSF1R antagonists readily cross the blood–brain barrier (BBB), they concurrently deplete both CNS microglia12–14 and macrophages13. As a result, this approach cannot address selectively the contribution of DRG macrophages. The same limitation confounds the interpretation of results from studies that used transgenic mouse lines that express a drug-inducible suicide gene, e.g., herpes simplex virus type 1 thymidine kinase (CD11b-TK)15 or diphtheria toxin receptor (CD11b-DTR16, LysM-DTR17, and Cx3cr1-DTR18) in both microglia and macrophages. As the drugs that induce killing readily cross the BBB, it is impossible to distinguish between the contribution of DRG macrophages and microglia18–20. A recent report21 took a different approach, using the macrophage Fas-induced apoptosis (MAFIA) transgenic mouse line22. As for the TK or DTR mice, this line expresses a suicide gene (Fas) under the control of the CSF1R promoter, which is specifically expressed in macrophages and microglia. In these mice, killing is provoked with an FK-binding protein dimerizer, AP20187 (AP). Based on reports that AP does not cross the BBB in MAFIA mice22, this approach has been used to kill macrophages selectively. Importantly, as this transgenic line coexpresses green fluorescent protein (GFP) under control of the same promoter, it is possible to monitor the distribution of cells that express the suicide gene and the extent of their depletion. Using the MAFIA mice, Shepherd et al.21 demonstrated reduced nerve injury-induced mechanical hypersensitivity, a hallmark of the neuropathic pain phenotype, after depletion of circulating monocytes and macrophages at the nerve injury site. Moreover, as these authors found that DRG macrophages were spared, they concluded that peripheral macrophages, but not those in the DRG, are the critical contributors to nerve injury-induced neuropathic pain21. However, their conclusion was not consistent with an earlier study reporting that selective depletion of peripheral monocytes/macrophages, while sparing DRG macrophages, had limited impact on neuropathic pain development6. Given the significant discrepancies in the literature, here we re-examined the question, again using the MAFIA mice. We administered AP systemically, before or after producing the peripheral nerve injury, so as to examine the contribution of peripheral macrophages to both the initiation and the maintenance of the mechanical hypersensitivity. We report that depletion of macrophages in the DRG, but not at the peripheral nerve injury site, can both prevent the development of and reverse ongoing nerve injury-induced mechanical hypersensitivity, in both male and female mice. In the context of nerve injury, we also uncovered a reciprocal cellular interaction between DRG macrophages and sensory neurons, one that we suggest is relevant to the DRG macrophage contribution to the neuropathic pain phenotype. RESULTS Nerve injury induces macrophage expansion in the DRG Using a fluorescence-activated cell sorting (FACS) analysis of dissociated DRG cells immunostained for the fractalkine receptor, CX3CR1, a marker that selectively defines peripheral monocytic cells and microglia6, we first quantified macrophages in the DRG after spared nerve injury (SNI). Figure 1a shows that 4 days after nerve injury (POD4), the CX3CR1+ cell population in the L4 and L5 DRG, ipsilateral to the nerve injury, increased by 2.9 ± 0.4-fold compared with the DRG on the contralateral, uninjured side. This ipsilateral expansion of macrophages persisted for at least 4 weeks after the nerve injury (POD28).Fig. 1Systemic AP treatment depletes macrophages in the DRG of MAFIA mice and delays mechanical allodynia.a FACS analysis of CX3CR1+ macrophage expansion in the L4/L5 DRG of wild-type mice after SNI (n = 6–7 per group). BL, baseline. POD, post-operative day. b FACS analysis of Ki67 expression in CX3CR1+ macrophages in the L4/L5 DRG of wild-type mice after nerve injury (n = 5 per group). c Representative images illustrating AP-induced depletion of GFP+ (green)/PU.1+(red) macrophages in the L4/L5 DRG of MAFIA mice injected with systemic AP (1.0 mg kg−1) for 3 days. NF200 (blue) marks myelinated neurons; scale bar: 50 μm. d FACS analysis of GFP+ DRG macrophages 1 day after the 3rd AP injection (nVEH = 9; nAP = 6). e, f SNI 1 day after AP or VEH treatment followed by FACS analysis of DRG macrophages on POD4 (e) and POD9 (f) (n = 5–6 per group). g qPCR analysis of Cx3cr1 gene expression in the L4/5 DRG of mice pretreated with AP or VEH on POD1 (n = 3 per group). h FACS analysis of GFP+ spinal cord microglia after a 3-day AP or VEH (n = 6 per group). i GFP+ (green) and Iba1+ (red) immunoreactive spinal cord microglia after a 3-day AP or VEH. Scale bar: 50 µm. j qPCR analysis of Cx3cr1 gene expression on POD1 in the lumbar spinal cord in mice pretreated with AP or VEH (n = 3 per group). k FACS analysis of GFP+ microglia in the